A Double-masked, Placebo-controlled Study With Open Label Period to Evaluate MEDI-551 in Neuromyelitis Optica and Neuromyelitis Optica Spectrum Disorders
ClinicalTrials.gov, 1 Oct 2015
Accessed on 17 Dec 2015 from https://www.clinicaltrials.gov/ct2/show/NCT02200770.